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Abstract
Background: Patients with psychiatric disorders were found to show a high seroprevalence of Toxoplasma gondii
infection. There is scarce information about the epidemiology of T. gondii infection in psychiatric patients in Mexico.
Therefore, we sought to determine the prevalence of T. gondii infection and associated socio-demographic, clinical and
behavioural characteristics in a population of psychiatric patients in Durango City, Mexico. Seroprevalence in patients
was compared with that obtained in a control population.
Methods: One hundred and thirty seven inpatients of a public psychiatric hospital and 180 controls were examined for
the presence of IgG and IgM antibodies against T. gondii by enzyme-linked immunoassay (Diagnostic Automation Inc.,
Calabasas, CA, USA). The control population consisted of blood donors of a public blood bank and elderly persons
attending a senior center in the same city. Age in controls (42 years +/- 20.2) was comparable with that of the psychiatric
patients (43.7 years +/-13.8) (p = 0.42). Socio-demographic, clinical and behavioral characteristics from the patients were
also obtained.
Results: Anti-T. gondii IgG antibodies indicating latent infection with T. gondii was found in 25 (18.2%) of 137 psychiatric
inpatients and 16 (8.9%) of 180 controls (p = 0.02). Ten (26.3%) of 38 schizophrenic patients had latent infection and this
prevalence was also significantly higher than that observed in controls (p = 0.005). Prevalence of anti-T. gondii IgM
antibodies was comparable among patients and controls (4.4% vs 2.2%, respectively, p = 0.22). Multivariate analysis
showed that T. gondii infection in inpatients was positively associated with sexual promiscuity (adjusted OR = 15.8; 95%
CI: 3.8–64.8), unwashed raw fruit consumption (adjusted OR = 5.19; 95% CI: 2.3–11.3), and a history of surgery (adjusted
OR = 6.5; 95% CI: 2.6–16), and negatively associated with lamb meat consumption (adjusted OR = 0.26; 95% CI: 0.10–
0.63).
Conclusion: In the present study, psychiatric inpatients in Durango, Mexico, in general and schizophrenia inpatients in
particular had a significantly higher prevalence of T. gondii infection than the control group. Results suggest that unwashed
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raw fruit consumption might be the most important route of T. gondii transmission in our psychiatric inpatients while
lamb meat consumption the less important. Additional studies will have to elucidate the causative relation between
infection with T. gondii and psychiatric disorders.
Background
Toxoplasma gondii (T. gondii) is a coccidian parasite found
worldwide [1,2], that infects nearly one third of humanity
[2,3]. Humans acquire a T. gondii infection mainly by
ingesting food or water that is contaminated with oocysts
shed by cats or by eating undercooked or raw meat con-
taining tissue cysts [3-5]. Primary infection acquired dur-
ing pregnancy may result in severe damage to the foetus
[3,6], and may cause mental retardation, seizures, blind-
ness, and death [7]. For its part, acquired infections in
humans are usually asymptomatic, but in some infected
persons cervical lymphadenopathy or ocular disease may
occur [1,3]. Acquired T. gondii infection in immunocom-
petent patients may also cause central nervous system
manifestations as Guillain-Barré syndrome [8], or cause a
brain abscess [9]. In addition, acquired acute toxoplasmo-
sis may be associated with psychiatric manifestations [10].
Yolken et al [11] have shown that individuals with first-
episode schizophrenia had significantly increased levels
of antibodies against T. gondii as compared with control
subjects. In a meta-analysis of 19 studies published since
1953 of T. gondii antibodies in persons with schizophre-
nia and other severe psychiatric disorders and in controls,
researchers found that 11 studies reported a significantly
higher percentage of antibodies in the affected persons
[12]. Most of the reported seroprevalence studies in psy-
chiatric patients were performed before 1980, and diag-
nostic methods used in these studies as skin test,
complement fixation, and colour change in fish, are less
specific than enzyme immunoassays used in the more
recent epidemiological studies [12]. Similarly, risk factors
for T. gondii infection in psychiatric patients have been
poorly explored. Due to the limited number of recent epi-
demiological studies in psychiatric patients in general,
and a lack of them in Mexico in particular, we have per-
formed a cross-sectional study in order to determine the
prevalence of T. gondii infection in psychiatric patients of
Durango City, Mexico. We also included in our study
investigations about the association between infection
and the patient characteristics including sociodemo-
graphic and clinical data as well as known risk factors for
infection. Results obtained were compared to a control
population of blood donors and elderly persons attend-
ing a senior center in the same Durango City.
Methods
Study populations
We have studied two populations: psychiatric inpatients
and control subjects.
Psychiatric inpatients
From December 2005 to March 2006, all inpatients of the
public psychiatric hospital of Durango City, Mexico were
invited to participate in the study. During the study
period, 158 patients were hospitalized. Out of the 158
inpatients, 137 were included in the study based on the
following criteria for inclusion: 1) psychiatric inpatients;
2) aged 16 years and older; and 3) who accepted to partic-
ipate in the study. Twenty one patients were excluded
because either they did not accept to participate, or did
not provide blood for analysis or did not submit the ques-
tionnaire. Thirty nine were females and 98 were males.
Inpatients had been hospitalised from 3 days to 46 years
(mean: 9.1 years). Ninety three patients suffered from an
acute psychiatric disease, and 44 from a chronic psychiat-
ric disease. Recent admissions (length of stay up to 2
months) were documented in 39 inpatients.
Control subjects
Since psychiatric patients had a wide range of age, we
included two control populations. One represented by
129 blood donors of a public blood bank and the other
consisted of 51 elderly persons attending a senior center
in Durango City. Inclusion criteria for blood donors were:
1) blood donors; 2) aged 16–54 years; and 3) who agreed
to participate in the study. In this study, we considered a
senior center as a place where the elderly attend courses
such as handicraft, dancing, primary school, high school,
singing, etc., and organize local and national travels for
pleasure. In elderly persons, inclusion criteria were: 1)
senior center attendees; 2) aged 55 years and older; and 3)
who agreed to participate in the study. All controls were
enrolled consecutively. Fifty five were females and 125
males. The mean age of the control subjects (42 years +/-
20.2) was comparable with that of the psychiatric patients
(43.7 years +/-13.8) (p = 0.42).
Socio-demographic, clinical and behavioural data
Socio-demographic data including age, birthplace, resi-
dence, marital status, occupation, educational level,
socio-economic level and housing conditions index were
obtained from all patients. Housing conditions index was
obtained by using the Bronfman's criteria [13]. Briefly,
five variables were evaluated: number of persons in the
house, number of rooms in the house, material of the
floor of the house, availability of drinkable water, and
form of elimination of excretes. Clinical data including
blood transfusion or transplant history; and behavioral
data including animal contacts, cleaning up cat faeces, for-BMC Infectious Diseases 2006, 6:178 http://www.biomedcentral.com/1471-2334/6/178
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eign travel, kind of meat consumption (pork, lamb, beef,
goat, boar, chicken, turkey, rabbit, deer, squirrel, horse,
sea food, snake and bird), raw or undercooked meat con-
sumption, unpasteurized milk or milk products con-
sumption, untreated water consumption, eating dried or
cured meat (chorizo, ham, sausages or salami), unwashed
raw vegetables or fruits consumption, contact with soil
(gardening or agriculture), and eating outside of the home
from the participants were obtained. Data was obtained
from the patients, medical examination records, and
informants. Patients were invited to provide veridical
information and they were informed that data were used
in a confidential manner. Classification of mental ill-
nesses was performed according to the ICD-10 criteria
[14].
Laboratory test
Sera of the participants were analysed for anti-T. gondii
IgG antibodies by a commercially available enzyme
immunoassay "Toxoplasma IgG" kit (Diagnostic Automa-
tion Inc., Calabasas, CA, USA). In addition, sera positive
for anti-T. gondii IgG antibodies were further analysed for
anti-T. gondii IgM antibodies by a commercially available
enzyme immunoassay "Toxoplasma IgM" kit (Diagnostic
Automation Inc., Calabasas, CA, USA).
Ethical aspects
This study was approved by the ethical committee of the
Hospital of Mental Health "Dr. Miguel Vallebueno", in
Durango City. The purpose and procedures of the study
were explained to all participants, and a written informed
consent was obtained from all of them.
Statistical Analysis
Results were analyzed with the aid of the software Epi Info
6 and SPSS 7.0. Age among the groups was compared by
the student's t  test. For comparison of the frequencies
among the groups, the Yates corrected test and when indi-
cated the Fisher exact test, were used. Bivariate and multi-
variate analyses were used to assess the association
between the characteristics of the subjects and T. gondii
infection. Variables were included in the multivariate
analysis if they had a p value of less than 0.20 in the bivar-
iate analysis. Adjusted odd ratio (OR) and 95% confi-
dence interval (CI) were calculated by multivariate
analysis using logistic regression.
Results
Seroprevalence of anti-T. gondii antibodies
Twenty-five (18.2%) of 137 psychiatric inpatients and 16
(8.9%) out of the 180 controls were positive for anti-T.
gondii IgG antibodies indicating latent infection with T.
gondii. Table 1 shows the seroprevalences of latent T. gon-
dii infection in the populations studied according to age
groups. Seroprevalence in patients and controls increased
with age (Table 1). However, patients in most age groups
showed higher rates of seroprevalence; whereas the differ-
ences in individual age groups did not reach statistical sig-
nificance, the difference among these prevalences in all
age groups taken together was statistically significant (p =
0.02).
Seroprevalence in patients with a long history of mental
disease was 25% (11/44) while seroprevalence in those
with recent onset of their mental illness was 15.1% (14/
93) (p = 0.24). Latent T. gondii infection was significantly
higher in schizophrenics (10/38, 26.3%) than in controls
(16/180, 8.9%) (p = 0.005). Table 2 shows the seropreva-
lences of T. gondii infection in the inpatients according to
their psychiatric disorder. The highest prevalence of latent
T. gondii infection in schizophrenics was found in patients
aged 45–54 years old (7/17, 41.2%) (Table 3). Latent T.
gondii infection was found in 3 (20%) of 15 schizophren-
ics females and 7 (30.4%) of 23 schizophrenic males.
Table 1: Seroprevalence of anti-T. gondii IgG antibodies in psychiatric patients and controls according to age groups.
Psychiatric patients Controls
T. gondii infection T. gondii infection
Age groups No. tested No. % No. tested No. % P value
16–24 8 0 0 40 2 5 0.69
25–34 30 5 16.7 48 3 6.3 0.13
35–44 27 4 14.8 32 4 12.5 0.54
45–54 33 8 24.2 9 1 11.1 0.36
55–64 17 5 29.4 8 1 12.5 0.34
65–74 6 0 0 31 5 16.1 0.38
75–84 4 1 25 12 0 0 0.25
16–84 125 23 18.4 180 16 8.9 0.02
Unknown age 12 2 16.7
All 137 25 18.2 180 16 8.9 0.02BMC Infectious Diseases 2006, 6:178 http://www.biomedcentral.com/1471-2334/6/178
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Anti-T. gondii antibodies were found in 5 (25%) of 20
acute schizophrenic patients and in 5 (27.8%) of 18
chronic schizophrenic patients. With respect to anti-T.
gondii IgM antibodies in persons with anti-T. gondii IgG
antibodies, we observed seropositivity in 6 (4.4%) psychi-
atric patients, 4 (2.2%) blood donors, and none of the
senior center attendees. No statistically significant differ-
ence in seroprevalence of anti-T. gondii IgM antibodies
was found between psychiatric patients and controls.
Factors associated with seropositivity
In the bivariate analysis, seven variables were identified as
possible risk factors associated with T. gondii infection: 1)
sexual promiscuity (0.04); 2) unwashed raw fruit con-
sumption (p = 0.06); 3) deer meat consumption (p =
0.07); 4) a history of surgery (p = 0.08), 5) being born out-
side Durango State (p = 0.10); 6) untreated water con-
sumption (p = 0.20); and 7) eating outside of the home (p
= 0.20). In addition, we found two variables that showed
possible negative association with T. gondii: 1) lamb meat
consumption (p = 0.06); and 2) pork meat consumption
(p = 0.18). The rest of the sociodemographic, clinical and
behavioural characteristics of patients did not show any
association with T. gondii infection. Multivariate analysis
(Table 4) revealed that only three variables were associ-
ated with T. gondii seropositivity: 1) sexual promiscuity
(adjusted OR = 15.8; 95% CI: 3.8–64.8); 2) unwashed raw
fruit consumption (adjusted OR = 5.19; 95% CI: 2.3–
11.3); and 3) a history of surgery (adjusted OR = 6.5; 95%
CI: 2.6–16). In addition, the multivariate analysis
revealed that only lamb meat consumption was negatively
associated with T. gondii infection (adjusted OR = 0.26;
95% CI: 0.10–0.63).
Discussion
In this study, we found an 18.2% prevalence of T. gondii
infection in psychiatric inpatients of Durango City, Mex-
ico. Reports on the prevalence of T. gondii infection
among populations of psychiatric inpatients are scarce. In
a previous Mexican study, Buentello [15] reported a sig-
nificantly higher prevalence of T. gondii infection in inpa-
tients with schizophrenia (29/42, 69%) than in normal
subjects (0/60, 0%). In a Cuban study, a 60% prevalence
of T. gondii infection was reported in psychiatric patients
admitted to wards of a teaching hospital and this preva-
lence was significantly higher than the one observed in
healthy subjects [16]. The prevalence found in our study
is much lower than that reported in the Cuban study. Nev-
ertheless, in both studies it became clear that psychiatric
patients showed significantly higher prevalences of T. gon-
dii infection than the control groups. The difference in the
prevalences among these studies might be explained by a
difference in the prevalence found in the general popula-
tion in each studied city. We recently found a prevalence
of 6.1% in pregnant women in Durango City [1] and
8.9% in our control population of the present study
whereas in the Cuban study the control healthy subjects
had a prevalence of 30% [16]. The difference in the prev-
alence among the psychiatric and control populations
might be explained, at least in part, by differences in the
sanitary conditions among the groups. Indeed, most psy-
chiatric inpatients belonged to a lower socio-economic
level and had lower housing conditions than the control
populations. Nevertheless, comparison of socio-eco-
nomic status among infected and not infected patients did
not show any statistically significant difference. We did
not find any difference in seroprevalence between patients
with a long history of mental disease versus those with
recent onset of their mental illness. Although the preva-
Table 2: Clinical diagnosis and seroprevalence of anti-T. gondii IgG antibodies in 137 psychiatric patients.
Clinical Diagnosis ICD-10 diagnosis Patients studied Patients with anti-T. gondii antibodies
No. % No. % P value*
Schizophrenia F20 38 27.7 10 26.3 0.005
Mental and behavioural disorders due to psychoactive substance use F14, F18–19 25 18.2 4 16 0.21
Mental disorder F06.2, F06.8–9 20 14.6 1 5 0.47
Mental retardation F71–73 19 13.9 4 21.1 0.1
Mental and behavioural disorders due to use of alcohol F10 14 10.2 2 14.3 0.38
Bipolar affective disorder F31 6 4.4 1 16.7 0.44
Epilepsy G40 4 3 0 0 0.69
Severe depressive episode F32.2–3 3 2.2 1 33.3 0.25
Dementia in Alzheimer's disease with early onset F00.0 2 1.5 2 100 0.009
Dissociative disorder F44 1 0.7 0 0 0.91
Vascular dementia F01 1 0.7 0 0 0.91
Somatoform disorder F45 1 0.7 0 0 0.91
Obsessive-compulsive disorder F42 1 0.7 0 0 0.91
Acute polymorphic psychotic disorder F23.1 1 0.7 0 0 0.91
Schizoaffective disorder, mixed type F25.2 1 0.7 0 0 0.91
All 137 100 25 18.2 0.02
*As compared with 8.9% seroprevalence of anti-T. gondii IgG antibodies in controls (16/180).BMC Infectious Diseases 2006, 6:178 http://www.biomedcentral.com/1471-2334/6/178
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lence of anti-T. gondii IgM antibodies was double in
patients than controls, no statistically significant differ-
ence was reached. This was most likely due to the low
numbers of positive subjects among the groups. When
specific diagnosis of psychiatric diseases were analysed
individually with respect to the prevalence of T. gondii
infection, we found a significantly higher prevalence in
schizophrenic patients than in the control population (p
= 0.005). However, we did not find any statistically signif-
icant difference in prevalence when age groups were com-
pared. This might be explained by the limited size of the
sample in each age group. The overall significantly higher
seroprevalence found in our schizophrenia patients than
our controls supports an association between T. gondii
infection and schizophrenia as other researchers have
reported. Yolken et al [11] showed that individuals with
first-episode schizophrenia had significantly increased
levels of antibodies against T. gondii as compared with
control subjects. Delgado-Garcia et al [17,18] found that
the highest percentage of skin-test-positive patients were
the most advanced schizophrenics, and the more severe
the patient state the higher the intensity of the test reactiv-
ity. Wang et al [19] showed that the seroprevalence of anti-
T. gondii IgG but not IgM-antibodies in schizophrenia
patients was higher than the seroprevalence in control
groups. Similarly, in a large study, Roch and Varela [20]
showed that schizophrenia patients had a significantly
higher prevalence of T. gondii infection than subjects of
the general population (836/973, 86% vs 4411/14689,
30%, respectively). Interestingly, all Alzheimer patients
included in the study had IgG-antibodies against T. gondii.
Since the number of patients was rather small, further
studies are needed to clarify this observation.
When the socio-demographic and behavioral characteris-
tics of the psychiatric patients were analysed by logistic
regression, we found that T. gondii infection was associ-
ated with sexual promiscuity (adjusted OR = 15.8; 95%
CI: 3.8–64.8). Interpretation of this finding should be
taken with care since the CI of the OR was wide. In addi-
tion, this finding is surprising since the sexual route seems
not to be effective in parasite transmission in men and
animals [21]. Nevertheless, this route can not be abso-
lutely excluded since T. gondii has been found in male
genital tract [22]. In addition, a history of surgery
(adjusted OR = 6.5; 95% CI: 2.6–16) was associated with
infection. This finding is also unexpected since none of
the patients had undergone transplantation and parasite
transmission by surgery other than transplantation has
not been described. Most likely, confounders have con-
tributed to the association of T. gondii infection with sex-
ual promiscuity and a history of surgery. Nevertheless, it
Table 3: Seroprevalence of anti-T. gondii IgG antibodies in schizophrenic patients and controls according to age groups.
Schizophrenic patients Controls
T. gondii infection T. gondii infection
Age groups No. Tested No. % No. tested No. % P value
25–34 5 0 0 48 3 6.3 0.73
35–44 6 1 16.7 32 4 12.5 0.59
45–54 17 7 41.2 9 1 11.1 0.12
55–64 5 1 20 8 1 12.5 0.64
65–74 2 0 0 31 5 16.1 0.71
75–84 3 1 33.3 12 0 0 0.2
All 38 10 26.3 140 14 10 0.01
Table 4: Multivariate analysis of characteristics of the psychiatric patients and their association with T. gondii infection.
Characteristica Adjusted odds ratiob 95% Confidence interval P value
Sexual promiscuity 15.8 3.8–64.8 0.0001
Unwashed raw fruit consumption 5.19 2.3–11.3 0.01
Deer meat consumption 0.93 0.37–2.30 0.87
Surgery history 6.5 2.6–16 <0.000
Being born outside Durango State 1.25 0.66–2.36 0.48
Untreated water consumption 1.4 0.72–2.86 0.29
Eating outside of the home 0.93 0.61–1.42 0.76
Lamb meat consumption 0.26 0.10–0.63 0.003
Pork meat consumption 0.37 0.11–1.17 0.09
aThe variables included were those with a p < 0.20 obtained in the bivariate analysis.
bAdjusted by gender and age.BMC Infectious Diseases 2006, 6:178 http://www.biomedcentral.com/1471-2334/6/178
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raises the question whether these characteristics might
reflect parasite-induced behavioral and clinical changes in
infected individuals. T. gondii-induced behavioral changes
have been reported in rats. Berdoy et al [23] showed in
wild/laboratory hybrid rats that the propensity to explore
novel stimuli in their environment was higher in T. gondii
infected than uninfected rats. In addition, Webster et al
[24] showed that in wild rats with naturally occurring T.
gondii infection low neophobia was significantly associ-
ated with positive Toxoplasma titers. Also in our study, we
found that unwashed raw fruit consumption was associ-
ated with infection (adjusted OR = 5.19; 95% CI: 2.3–
11.3), and this finding suggests that contaminated fruit
probably by cat feces might also be important in parasite
transmission in psychiatric patients. Known factors asso-
ciated with T. gondii infection in other populations as con-
tact with cats [25], drinking untreated water [26-28],
contact with garden soil [29], and consumption of cured
meat [30], were not associated with T. gondii infection in
our study. On the other hand, we found that T. gondii
infection in the psychiatric patients was negatively associ-
ated with lamb meat consumption (adjusted OR = 0.26;
95% CI: 0.10–0.63). This finding suggests that consump-
tion of this meat played no role in parasite transmission
in our psychiatric patients.
Conclusion
We conclude that psychiatric inpatients in general and
schizophrenia inpatients in particular had a significantly
higher prevalence of T. gondii infection than the control
group. Results suggest that unwashed raw fruit consump-
tion indicating environmental contamination with
oocysts might be the most important route of T. gondii
transmission in our psychiatric inpatients. Additional
studies will have to elucidate the causative relation
between infection with T. gondii and psychiatric disorders.
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